A rapid nanobiosensing platform based on herceptin-conjugated graphene for ultrasensitive detection of circulating tumor cells in early breast cancer

In this paper, we use a simple and cheap approach for the synthesis of herceptin-conjugated graphene biosensor to detect the HER2-positive breast cancer cells. The bifunctional graphene-herceptin nanosheets are prepared from graphite by a simple ultrasonic-mediated technique. The prepared protein-me...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rahimzadeh Zahra, Naghib Seyed Morteza, Askari Esfandyar, Molaabasi Fatemeh, Sadr Ali, Zare Yasser, Afsharpad Mandana, Rhee Kyong Yop
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2021
Materias:
T
Acceso en línea:https://doaj.org/article/5910230ca4d0490d9892898668a5f7a0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5910230ca4d0490d9892898668a5f7a0
record_format dspace
spelling oai:doaj.org-article:5910230ca4d0490d9892898668a5f7a02021-12-05T14:10:57ZA rapid nanobiosensing platform based on herceptin-conjugated graphene for ultrasensitive detection of circulating tumor cells in early breast cancer2191-909710.1515/ntrev-2021-0049https://doaj.org/article/5910230ca4d0490d9892898668a5f7a02021-08-01T00:00:00Zhttps://doi.org/10.1515/ntrev-2021-0049https://doaj.org/toc/2191-9097In this paper, we use a simple and cheap approach for the synthesis of herceptin-conjugated graphene biosensor to detect the HER2-positive breast cancer cells. The bifunctional graphene-herceptin nanosheets are prepared from graphite by a simple ultrasonic-mediated technique. The prepared protein-mediated graphene is fully characterized. The results show the exfoliation of graphene layers in herceptin solution. Moreover, herceptin is effectively conjugated into the surface of graphene nanosheets. The synthesized herceptin-conjugated graphene is applied for breast cancer detection. The linear range of this biosensor is 1–80 cells, which is significant. The biosensor shows an excellent selectivity performance for detection of HER2-positive cancer cells. Likewise, the stability and functionality of the biosensor is about 40 days. Based on the results, this device is a promising candidate for rapid and selective detection of cancer cells.Rahimzadeh ZahraNaghib Seyed MortezaAskari EsfandyarMolaabasi FatemehSadr AliZare YasserAfsharpad MandanaRhee Kyong YopDe Gruyterarticlesingle cellbreast cancerimmunosensorherceptingrapheneTechnologyTChemical technologyTP1-1185Physical and theoretical chemistryQD450-801ENNanotechnology Reviews, Vol 10, Iss 1, Pp 744-753 (2021)
institution DOAJ
collection DOAJ
language EN
topic single cell
breast cancer
immunosensor
herceptin
graphene
Technology
T
Chemical technology
TP1-1185
Physical and theoretical chemistry
QD450-801
spellingShingle single cell
breast cancer
immunosensor
herceptin
graphene
Technology
T
Chemical technology
TP1-1185
Physical and theoretical chemistry
QD450-801
Rahimzadeh Zahra
Naghib Seyed Morteza
Askari Esfandyar
Molaabasi Fatemeh
Sadr Ali
Zare Yasser
Afsharpad Mandana
Rhee Kyong Yop
A rapid nanobiosensing platform based on herceptin-conjugated graphene for ultrasensitive detection of circulating tumor cells in early breast cancer
description In this paper, we use a simple and cheap approach for the synthesis of herceptin-conjugated graphene biosensor to detect the HER2-positive breast cancer cells. The bifunctional graphene-herceptin nanosheets are prepared from graphite by a simple ultrasonic-mediated technique. The prepared protein-mediated graphene is fully characterized. The results show the exfoliation of graphene layers in herceptin solution. Moreover, herceptin is effectively conjugated into the surface of graphene nanosheets. The synthesized herceptin-conjugated graphene is applied for breast cancer detection. The linear range of this biosensor is 1–80 cells, which is significant. The biosensor shows an excellent selectivity performance for detection of HER2-positive cancer cells. Likewise, the stability and functionality of the biosensor is about 40 days. Based on the results, this device is a promising candidate for rapid and selective detection of cancer cells.
format article
author Rahimzadeh Zahra
Naghib Seyed Morteza
Askari Esfandyar
Molaabasi Fatemeh
Sadr Ali
Zare Yasser
Afsharpad Mandana
Rhee Kyong Yop
author_facet Rahimzadeh Zahra
Naghib Seyed Morteza
Askari Esfandyar
Molaabasi Fatemeh
Sadr Ali
Zare Yasser
Afsharpad Mandana
Rhee Kyong Yop
author_sort Rahimzadeh Zahra
title A rapid nanobiosensing platform based on herceptin-conjugated graphene for ultrasensitive detection of circulating tumor cells in early breast cancer
title_short A rapid nanobiosensing platform based on herceptin-conjugated graphene for ultrasensitive detection of circulating tumor cells in early breast cancer
title_full A rapid nanobiosensing platform based on herceptin-conjugated graphene for ultrasensitive detection of circulating tumor cells in early breast cancer
title_fullStr A rapid nanobiosensing platform based on herceptin-conjugated graphene for ultrasensitive detection of circulating tumor cells in early breast cancer
title_full_unstemmed A rapid nanobiosensing platform based on herceptin-conjugated graphene for ultrasensitive detection of circulating tumor cells in early breast cancer
title_sort rapid nanobiosensing platform based on herceptin-conjugated graphene for ultrasensitive detection of circulating tumor cells in early breast cancer
publisher De Gruyter
publishDate 2021
url https://doaj.org/article/5910230ca4d0490d9892898668a5f7a0
work_keys_str_mv AT rahimzadehzahra arapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT naghibseyedmorteza arapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT askariesfandyar arapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT molaabasifatemeh arapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT sadrali arapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT zareyasser arapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT afsharpadmandana arapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT rheekyongyop arapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT rahimzadehzahra rapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT naghibseyedmorteza rapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT askariesfandyar rapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT molaabasifatemeh rapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT sadrali rapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT zareyasser rapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT afsharpadmandana rapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
AT rheekyongyop rapidnanobiosensingplatformbasedonherceptinconjugatedgrapheneforultrasensitivedetectionofcirculatingtumorcellsinearlybreastcancer
_version_ 1718371536630448128